Nippon India Pharma Fund
Holdings
35
Concentrated
Top 10 weight
59%
Concentration
Active share
90%
Highly Differentiated
Equity
98%
Asset allocation
Portfolio
3Sectors
6Large positions
72.3%Top: Pharmaceuticals & Biotechnology
2.2%Cash
Market-cap allocation
Large cap40%
Mid cap27%
Small cap30%
Asset allocation
Equity98%
Cash2%
Top holdings
13.3%
Lupin LimitedEQUITY
7.3%6.7%
Cipla LimitedEQUITY
6.2%5.8%
5.2%
Mankind Pharma LimitedEQUITY
3.9%3.7%
3.4%
Ajanta Pharma LimitedEQUITY
3.2%3.2%
3.0%
2.6%
2.4%
2.3%
Aurobindo Pharma LimitedEQUITY
2.3%Abbott India LimitedEQUITY
2.3%Triparty RepoCASH
2.2%Gland Pharma LimitedEQUITY
2.1%2.1%
1.9%
1.8%
1.8%
Pfizer LimitedEQUITY
1.7%1.5%
1.3%
1.2%
1.1%
0.93%
0.92%
Sanofi India LimitedEQUITY
0.83%Biocon LimitedEQUITY
0.73%0.63%
Indoco Remedies LimitedEQUITY
0.45%Concord Biotech LimitedEQUITY
0.14%AI Smart summary
Portfolio read
- 98% equity, 2% cash.
- 35 disclosed positions across 3 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 72.3% of the portfolio.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 72%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund291 holdings · 33% top 10 · 36% AS
Bandhan Business Cycle Fund95 holdings · 35% top 10 · 65% AS
WhiteOak Capital Special Opportunities Fund91 holdings · 29% top 10 · 73% AS
UTI Quant Fund90 holdings · 35% top 10 · 66% AS
ICICI Prudential Manufacturing Fund86 holdings · 37% top 10 · 79% AS
Axis India Manufacturing Fund86 holdings · 34% top 10 · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
72.3%
21.9%
3.7%